Edarbi azilsartan medoxomil is an antihypertensive drug indicated for the treatment of hypertension. If blood pressure is not controlled magnesium and rheumatoid arthritis Edarbi alone, additional blood pressure reduction can be achieved by taking Edarbi with other antihypertensive agents. Common side effects of Edarbi include:. The recommended dose of Edarbi in adults is 80 mg lotrel and sleeping orally once daily.
A starting dose of 40 mg is considered for patients who are treated with high doses of diuretics. Lotrel and sleeping may interact with other heart or blood pressure medications, diuretics water pillsor nonsteroidal anti-inflammatory drugs NSAIDs.
Tell your doctor all medications and supplements you use, lotrel and sleeping. Do not use Edarbi if you are pregnant, and stop using if you become pregnant. Edarbi can cause injury or death lotrel and sleeping the fetus if taken during the second or third trimester.
Use effective birth control. It is unknown if Edarbi passes into breast milk or if it could harm a nursing baby. Breastfeeding while taking Edarbi is not motrin and doses. Our Edarbi azilsartan medoxomil Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. Get emergency medical help if you have any of these signs of an allergic reaction: Read the entire detailed patient monograph for Edarbi azilsartan medoxomil. Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in practice, lotrel and sleeping.
A total of patients were evaluated for safety when treated with Edarbi at doses of 20, 40, or 80 mg in clinical trials. This includes patients treated for at least six months; of these, were treated for at least one year. Treatment with Edarbi was well-tolerated with an overall incidence of adverse reactions similar to placebo, lotrel and sleeping.
The rate of withdrawals due to adverse events in placebo-controlled monotherapy and combination therapy trials was 2. Generally, adverse reactions were mild, not dose related, and similar regardless of age, lotrel and sleeping, gender, and race.
General Disorders and Administration Site Conditions: In controlled clinical trials, clinically relevant changes in standard laboratory parameters were uncommon with administration of Edarbi. Small reversible increases in serum creatinine are seen in patients receiving 80 mg of Lotrel and sleeping. The increase may be larger when coadministered with chlorthalidone or hydrochlorothiazide. Low hemoglobinhematocrit pregnancy and ampicillin 500, and RBC counts were observed in 0.
None of these abnormalities were reported in the placebo group. Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure. Read the entire FDA prescribing information for Edarbi azilsartan medoxomil. Last reviewed on RxList: Lotrel and sleeping Side Effects Center. Find Lowest Prices on. High Blood Pressure Slideshow Pictures. Take the Salt Quiz!
Call your doctor at once if lotrel and sleeping have: Common side effects may include: SIDE EFFECTS Clinical Trials Experience Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in practice.
Serum Creatinine Small reversible increases in serum creatinine are seen in patients receiving 80 mg of Edarbi. Related Resources for Edarbi.